Disappointment indeed for all involved, Treagus and Walker...

Disappointment indeed for all involved, Treagus and Walker included. They surrepticiously set up a special purpose trust in Auckland to acquire sufficient holdings to then transfer control to Melbourne. Touted as a new era for progress, veiled intimations were made of corporate deals to come with breakthrough advances likely in neurlogical disease care. Arcadia then paid $4 a share to gain exclusive access to future research and any sales thereafter all at their expense. All looked rosy, then boom! Our intrepid duo fled dramatically without explanation, selling down at rock bottom prices, leaving their erstwhile financial controller in charge. What happened and why have we had total silence regarding this episode? Were they partial to confidential information? After all their patient efforts to gain control, it leaves one suspicious that there is more to this story that is yet to be revealed. In the mean time(2 years) we long term and serious holders(plus personal friends who bought on my enthusiasm for this stock) are left in the lurch with heavy financial losses.
Will the trial results be sufficiently robust this time around to promote clinical sales?